المؤلفون: Shimada S; Division of Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake Koto-ku, Tokyo, 135-8550, Japan.; Department of Breast Oncology, Juntendo University, Tokyo, Japan., Yoshida R; Division of Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake Koto-ku, Tokyo, 135-8550, Japan. reiko.yoshida@jfcr.or.jp., Nakashima E; Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Kitagawa D; Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Gomi N; Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Diagnostic Imaging Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Horii R; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Takeuchi S; Division of Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake Koto-ku, Tokyo, 135-8550, Japan., Ashihara Y; Division of Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake Koto-ku, Tokyo, 135-8550, Japan., Kita M; Division of Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake Koto-ku, Tokyo, 135-8550, Japan., Akiyama F; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Ohno S; Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Saito M; Department of Breast Oncology, Juntendo University, Tokyo, Japan., Arai M; Division of Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake Koto-ku, Tokyo, 135-8550, Japan.; Diagnostics and Therapeutics of Intractable Disease, Graduate School of Medicine, Juntendo University, Tokyo, Japan.

المصدر: Breast cancer (Tokyo, Japan) [Breast Cancer] 2019 Nov; Vol. 26 (6), pp. 846-851. Date of Electronic Publication: 2019 Apr 12.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Genes, BRCA1* , Genes, BRCA2* , Mass Screening* , Mutation*, BRCA1 Protein/*genetics , BRCA2 Protein/*genetics , Breast Neoplasms/*diagnosis , Breast Neoplasms/*genetics, Adult ; Breast Neoplasms/surgery ; Early Detection of Cancer/methods ; Female ; Genetic Predisposition to Disease ; Genetic Testing ; Humans ; Magnetic Resonance Imaging ; Mammography ; Mastectomy ; Middle Aged ; Risk ; Tokyo ; Treatment Outcome